Novel advances in inhibiting advanced glycation end product formation using natural compounds

Biomedicine & Pharmacotherapy
2021.0

Abstract

Advanced glycation end products (AGEs) are a group of complex compounds generated by nonenzymatic interactions between proteins and reducing sugars or lipids. AGEs accumulate in vivo and activate various signaling pathways closely related to the occurrence of various chronic metabolic diseases. In this paper, we describe the process through which AGEs are formed, the classification of AGEs, and biological effects of AGEs on human health. Most importantly, we review recent progress in natural compound-based AGE formation inhibitors. Major classes of natural inhibitors, including polyphenols, polysaccharides, terpenoids, vitamins and alkaloids, have been described. Their mechanisms of action have been summarized as scavenging free radicals, chelating metal ions, capturing active carbonyl compounds, protecting protein glycation sites, and lowering blood glucose levels. Although these natural compounds have good antiglycation activity, to date, they are not widely used in the clinic, likely because of their low content levels. However, these natural compounds and their molecular frameworks will play a valuable role in inspiring drug discovery. © 2021 The Authors

Knowledge Graph

Similar Paper

Novel advances in inhibiting advanced glycation end product formation using natural compounds
Biomedicine & Pharmacotherapy 2021.0
Second generation 2-aminoimidazole based advanced glycation end product inhibitors and breakers
Bioorganic & Medicinal Chemistry Letters 2015.0
Advanced Glycation End Product Inhibition by Alkaloids from Ocotea paranapiacabensis for the Prevention of Skin Aging
Journal of Natural Products 2020.0
Inhibitory activity of coumarins from Artemisia capillaris against advanced glycation endproduct formation
Archives of Pharmacal Research 2012.0
Multifunctional diamine AGE/ALE inhibitors with potential therapeutical properties against Alzheimer's disease
European Journal of Medicinal Chemistry 2016.0
Flavan-3-ols Having a .GAMMA.-Lactam from the Roots of Actinidia arguta Inhibit the Formation of Advanced Glycation End Products in Vitro
Chemical and Pharmaceutical Bulletin 2009.0
Inhibitors of Aldose Reductase and Formation of Advanced Glycation End-Products in Moutan Cortex (<i>Paeonia suffruticosa</i>)
Journal of Natural Products 2009.0
N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation
Bioorganic &amp; Medicinal Chemistry 2009.0
Synthesis and antiglycation potentials of bergenin derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Journal of Medicinal Chemistry 2017.0